RNA

Prosensa Holding N.V. News Headlines

$5.07
*  
0.39
 negative 
8.33%
Get RNA Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Prosensa Rises on Encouraging Data - Analyst Blog
3/19/2014 5:20:01 PM - Zacks.com

Prosensa Holding N.V. Q4 13 Earnings Conference Call At 8:00 AM ET
3/18/2014 7:00:00 AM - RTT News

ATEC Sees Growth, FPRX Gets High-Five, RNA Walks The Talk, RPRX On The Move
3/18/2014 1:39:00 AM - RTT News

Prosensa Shares Jump on 'Encouraging' Phase II Drug Study
3/17/2014 7:28:00 PM - Dow Jones Business News

Do Away With The Pill-A-Day Biotech Model: Steve Brozak
2/7/2014 2:05:00 PM - Seeking Alpha

Isis Pharmaceuticals, Inc. (ISIS): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/21/2014 8:00:01 AM - Zacks.com

Sarepta Therapeutics: Underappreciated Clinical And Regulatory Risk Following Analysis Of Prosensa Failure
10/30/2013 11:12:00 AM - Seeking Alpha

Sarepta On The Move
10/21/2013 3:44:00 PM - Seeking Alpha

Archived Event: interview with Hans GCP Schikan, CEO Prosensa Holding B.V. (RNA)
10/18/2013 6:38:18 PM - Nasdaq CEO Signature Series

Sarepta Shares Continue to Inch Up - Analyst Blog
9/30/2013 4:42:41 PM - Zacks.com

Is It Time To Go Long Sarepta Therapeutics?
9/26/2013 2:34:00 PM - Seeking Alpha

Sarepta Therapeutics: A Bigger Cake Outweighs A Lower Chance For A Party
9/23/2013 3:47:00 PM - Seeking Alpha

Prosensa Collapses on Drug Trial Failure - Analyst Blog
9/23/2013 12:53:08 PM - Zacks.com

Phase III Trial Ruins Prosensa's Drisapersen, Sarepta Rallies Strongly
9/23/2013 9:30:00 AM - Seeking Alpha

Prosensa: One Duchenne Therapy Down
9/20/2013 11:05:00 AM - Seeking Alpha

Stocks Mixed Ahead of Fed Chatter, Debt Ceiling Debate
9/20/2013 9:09:11 AM - MT Newswires

Pre-Market Most Active for Sep 20, 2013 : RNA, SRPT, JCP, SNY, ALU, SIRI, NOK, FB, JKS, BUD, AAPL, MSFT
9/20/2013 8:40:01 AM - NASDAQ.com News

Sector Update: Healthcare Shares Mixed Pre-Market; Sarepta Sinks 10% on GlaxoSmithKline, Prosensa Study
9/20/2013 8:22:09 AM - MT Newswires

Sector Update: Healthcare
9/20/2013 8:17:31 AM - MT Newswires

Insiders Are Buying Sarepta Therapeutics
8/25/2013 7:01:00 PM - Seeking Alpha

Wedbush Expert Declares Money For Biotech Is Still Out There
8/9/2013 11:47:00 AM - Seeking Alpha

Prosensa prices IPO at $13, the high end of the range
6/27/2013 7:14:43 PM - Renaissance Capital

IPO Preview: Prosensa Holding B.V.
6/27/2013 4:56:00 PM - Seeking Alpha

3 New Healthcare IPOs For June 24th Week
6/25/2013 1:30:00 PM - Seeking Alpha

U.S. IPO Recap: Biotech Success Continues, But 3 Deals Delayed Or Postponed
6/24/2013 1:56:00 PM - Seeking Alpha